Targeting of the GPCR, relaxin family peptide receptor 1 (RXFP1) (#15)
M. Akhter Hossain
1
,
Martina Kocan
2
,
Vinojini Nair
3
,
John Karas
3
,
Nitin Patil
1
,
Julien Tailhades
3
,
Johan Rosengren
4
,
Chrishan Samuel
5
,
Ross Bathgate
3
,
John Wade
1
- Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia
- Monash Institute of Pharmaceutical Sciences, Parkville
- Florey Institute of Neuroscience and Mental Health, Parkville, Australia
- School of Biomedical Sciences, the University of Queensland, Brisbane, Australia
- Department of Pharmacology, Monash University, Clayton, Australia
Publish consent withheld
- Hossain MA, Wade JD. Curr Opin Chem Biol. 2014, 22:47-55.
- Grosse J, Heffron H, Burling K, Hossain MA, Habib AM, Rogers GJ, Richards P, Larder R, Rimmington D, Adriaenssens AA, Parton L, Powell J, Binda M, Colledge WH, Doran J, Toyoda Y, Wade JD, Aparicio S, Carlton MB, Coll AP, Reimann F, O'Rahilly S, Gribble FM. Proc Natl Acad Sci, U S A. 2014, 111: 11133-8.
- Karas JA, Scanlon DB, Forbes BE, Vetter I, Lewis RJ, Gardiner J, Separovic F, Wade JD, Hossain MA. Chemistry. 2014, 20: 9549-52.
- Belgi A, Bathgate RA, Kocan M, Patil N, Zhang S, Tregear GW, Wade JD, Hossain MA. J Med Chem. 2013, 56: 9509-16.